C5ORF43 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.893400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.453440E-01
Normal-vs-Stage2
2.756000E-01
Normal-vs-Stage3
9.320000E-01
Normal-vs-Stage4
2.143200E-01
Stage1-vs-Stage2
3.064000E-01
Stage1-vs-Stage3
1.424040E-01
Stage1-vs-Stage4
3.836400E-01
Stage2-vs-Stage3
2.541800E-01
Stage2-vs-Stage4
3.199200E-01
Stage3-vs-Stage4
1.670150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.010600E-01
Normal-vs-AfricanAmerican
3.921000E-01
Normal-vs-Asian
3.811800E-01
Caucasian-vs-AfricanAmerican
7.666200E-01
Caucasian-vs-Asian
9.171600E-01
AfricanAmerican-vs-Asian
8.801000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.968400E-01
Normal-vs-Female
2.893400E-01
Male-vs-Female
9.890400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.309600E-01
Normal-vs-Age(41-60Yrs)
1.483160E-01
Normal-vs-Age(61-80Yrs)
3.860600E-01
Normal-vs-Age(81-100Yrs)
3.049400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.848400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.879800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.320800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.613250E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.488400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.406000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.442000E-01
Normal-vs-Daily Drinker
4.378400E-01
Normal-vs-Weekly Drinker
6.699000E-01
Normal-vs-Occasional Drinker
1.496970E-01
Normal-vs-Social Drinker
2.346600E-01
Non Drinker-vs-Daily Drinker
7.771000E-01
Non Drinker-vs-Weekly Drinker
6.272200E-01
Non Drinker-vs-Occasional Drinker
5.037900E-02
Non Drinker-vs-Social Drinker
8.753600E-01
Daily Drinker-vs-Weekly Drinker
5.245800E-01
Daily Drinker-vs-Occasional Drinker
1.384780E-01
Daily Drinker-vs-Social Drinker
8.910200E-01
Weekly Drinker-vs-Occasional Drinker
6.078300E-02
Weekly Drinker-vs-Social Drinker
5.367000E-01
Occasional Drinker-vs-Social Drinker
7.896100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.896000E-02
Normal-vs-Grade 2
5.857100E-03
Normal-vs-Grade 3
4.438200E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.912200E-01
Grade 1-vs-Grade 3
4.274600E-01
Grade 1-vs-Grade 4
3.896000E-02
Grade 2-vs-Grade 3
8.101400E-01
Grade 2-vs-Grade 4
5.857100E-03
Grade 3-vs-Grade 4
4.438200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.699400E-01
Normal-vs-NonDiabetic
2.578600E-01
Diabetic-vs-NonDiabetic
1.978770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.645400E-01
Normal-vs-NoPancreatitis
3.217800E-01
Pancreatitis-vs-NoPancreatitis
8.882500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.483000E-01
Normal-vs-N1
3.053200E-01
N0-vs-N1
8.117200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.863600E-02
Normal-vs-TP53-NonMutant
2.689400E-01
TP53-Mutant-vs-TP53-NonMutant
6.396000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
